Navigation Links
Pennside To Send Expert Oncology Team to 2013 ASCO Conference
Date:5/16/2013

Wyomissing, PA (PRWEB) May 16, 2013

Pennside Partners Ltd, a full-service pharmaceutical and biotechnology consulting firm, will send a contingent of nine oncology experts to attend the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) to be held May 31-June 4 in Chicago. The team will gather and document information from numerous presentations and gain valuable insights from interactions with oncologists, nurses, allied health professionals and patient advocates who are key thought leaders in their field.

“This is the most important oncology conference of the year,” said Judi Space, Pennside’s Director of Oncology. “As experts in the field of oncology, it is imperative that we capture this vital meeting virtually in its entirety. We always have a large team at ASCO in order to fully analyze the implications of the latest research for pharma and biotech companies. Insights provided by these experts deepen our knowledge and understanding of the oncology universe.”

ASCO features cutting-edge scientific presentations and comprehensive educational content. Over 25,000 oncology professionals from a broad range of specialties are expected to attend. The latest breakthroughs in progress against cancer based on over 5,000 abstracts will be showcased, with important and sometimes immediate implications for patient care and practice. New data releases for every cancer tumor type will be presented with important breakthroughs showcased at large plenary sessions attended by thousands of oncology professionals.

A key theme of the conference is the burgeoning use of immunotherapies, including vaccines and PD-1 agents, in multiple oncology indications. This relatively new area of therapeutics builds on earlier successes of CTLA4 blockade and the prostate cancer vaccine to offer the promise of new options after many years of failures. Another important theme is the use of molecular subtyping through whole genome analysis as a way to properly direct therapy in an exceptionally personalized way.

About Pennside Partners Ltd
Pennside Partners Ltd is a leading business development consulting firm serving the pharmaceutical, biotechnology, and medical device sectors worldwide. Pennside’s expert team includes an extensive in-house staff of highly qualified MDs, pharmacists, nurses, scientists, and marketing and sales experts, combined with an expansive network of contacts throughout North America, Europe, Asia, and South America, supplemented by an exclusive key opinion leader database. As a result, the needs of their pharma and biotech clients receive immediate attention in the form of incisive and actionable intelligence that clients leverage to receive a stronger return on their business development, competitive intelligence, and launch planning efforts.

Pennside’s mission is to help their pharma and biotech clients rapidly formulate winning strategies & tactics by providing the industry’s most accurate business intelligence and market insight. Find them at http://www.Pennside.com

About The American Society of Clinical Oncology (ASCO)
ASCO promotes and provides for lifelong learning for oncology professionals; cancer research; an improved environment for oncology practice; access to quality cancer care; a global network of oncology expertise; and educated and informed patients with cancer. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. Find them at http://www.ASCO.org

Read the full story at http://www.prweb.com/releases/Oncology-Consultants/ASCO-2013/prweb10733889.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Experts Offer Advice After Yankee Pitchers Trampoline Injury
2. NYU Langone experts present research, clinical advances at neurosurgeons meeting
3. Red Tide Likely in New England This Season, Experts Warn
4. No Proof That Gum Disease Causes Heart Disease, Experts Say
5. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
6. Glaucoma Need Not Steal Sight, Experts Say
7. Close Laundry Detergent Right After Use, Expert Says
8. Healthy Behaviors Extend Life After Cancer, Experts Say
9. More Babies Today Have Irregular Head Shape: Expert
10. Routine Kidney Disease Screening Not Worthwhile, Experts Say
11. Exercise Twice a Day Vital for Your Dogs Health, Expert Says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
Breaking Medicine Technology: